Triamcinolone and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Triamcinolone (triamcinolone), especially for people who are female, 40-49 old, also take Seroquel, and have Depression.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Triamcinolone. It is created by eHealthMe based on reports of 25,490 people who have side effects when taking Triamcinolone from the FDA, and is updated regularly.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,641 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On Jul, 11, 2026

25,490 people reported to have side effects when taking Triamcinolone.
Among them, 17 people (0.07%) have Type 1 diabetes.

Could Triamcinolone cause Type 1 diabetes?

Among these 17 people:

What is the gender of people who have Type 1 diabetes when taking Triamcinolone? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Type 1 diabetes when taking Triamcinolone? *

What are other drugs people take besides Triamcinolone? *

What are other side effects people have besides Type 1 diabetes? *

Type 2 Diabetes: 5 people, 29.41%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 3 people, 17.65%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 17.65%
Death: 3 people, 17.65%
Sleep Apnea Syndrome: 3 people, 17.65%
Fluid Overload (too much fluid in the blood): 2 people, 11.76%
Migraine (headache): 2 people, 11.76%
Kidney Infection (Pyelonephritis): 2 people, 11.76%
Hypotension (abnormally low blood pressure): 2 people, 11.76%
High Blood Pressure: 2 people, 11.76%

What are the existing conditions these people have? *

Depression: 5 people, 29.41%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 17.65%
Post-Traumatic Stress Disorder: 2 people, 11.76%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 2 people, 11.76%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 11.76%
Stress And Anxiety: 2 people, 11.76%
Sleep Disorder: 2 people, 11.76%
Seasonal Allergy (allergic condition due to certain season): 2 people, 11.76%
Pain: 2 people, 11.76%
Hypersensitivity: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triamcinolone:

Triamcinolone (25,577 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,845 reports)

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,641 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone (the active ingredients of Triamcinolone) and Triamcinolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.